共 50 条
- [21] Effect of insulin glargine and NPH on quality of life in patients with type 2 diabetes mellitus[J]. VALUE IN HEALTH, 2006, 9 (06) : A237 - A237Gupta, K.Gupta, U.Singh, N.
- [22] Diabetic retinopathy and insulin glargine[J]. DIABETOLOGIA, 2009, 52 (10) : 2233 - 2233Chantelau, E.
- [23] Diabetic retinopathy and insulin glargine[J]. Diabetologia, 2009, 52 : 2233 - 2233E. Chantelau
- [24] Beneficial effects of insulin glargine compared to NPH in subjects with type 1 diabetes.[J]. DIABETOLOGIA, 2001, 44 : A15 - A15Hershon, KBlevins, TDonley, DLittlejohn, C
- [25] Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes[J]. PEDIATRIC DIABETES, 2008, 9 (03) : 83 - 90Paivarinta, MinnaTapanainen, PaiviVeijola, Riitta
- [26] Insulin glargine is associated with less hypoglycaemia than NPH insulin in older patients with Type 2 diabetes[J]. DIABETOLOGIA, 2004, 47 : A328 - A328Riddle, MMassi-Benedetti, MHäring, HUDailey, GMurray, FLin, ZRosenstock, J
- [27] Economic evaluation of the use of insulin glargine compared with NPH insulin in patients with Type 2 diabetes in Spain[J]. DIABETOLOGIA, 2004, 47 : A344 - A344Rodríguez, JTerrés, CRBolinder, Bde Pablos, P
- [28] The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 1 diabetes[J]. VALUE IN HEALTH, 2006, 9 (06) : A225 - A226McEwan, P.Poole, C. D.Holmes, P.Tetlow, A. P.Currie, C. J.
- [29] Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study[J]. DIABETOLOGIA, 2009, 52 (09) : 1778 - 1788Rosenstock, J.Fonseca, V.McGill, J. B.Riddle, M.Halle, J. -P.Hramiak, I.Johnston, P.Davis, M.
- [30] A randomized, multicentre trial of insulin glargine versus NPH insulin in people with Type 1 diabetes.[J]. DIABETOLOGIA, 2002, 45 : A258 - A258Home, P